Citurgia Biochemicals has informed that it enclosed revised Standalone audited Financial Results for the quarter and year ended on 31st March, 2023. Also informed the Query raised by Exchange that ‘Financial result is not signed by the chairperson or managing director, or a whole time director or in the absence of all, other authorized director. Company is requested to confirm compliance of Regulation 33(2)(b).’ In this regard, it also confirmed that the financials were signed by the Whole time director of the company but the designation was mentioned wrongly ‘Director instead of Whole time Director’ in the submission dated 27th July, 2013. The Company has already complied with Regulation 33(2)(b).’
The above information is a part of company’s filings submitted to BSE.
